| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/1744666X.2015.1080121 |
| P698 | PubMed publication ID | 26295486 |
| P2093 | author name string | Ricardo Forastiero | |
| Marta Martinuzzo | |||
| P2860 | cites work | International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 |
| Heart disease and stroke statistics--2011 update: a report from the American Heart Association | Q29547236 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases | Q33498243 | ||
| Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome | Q33723441 | ||
| Which are the best biological markers of the antiphospholipid syndrome? | Q34021258 | ||
| Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature | Q34977289 | ||
| Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome | Q35158386 | ||
| Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus | Q36709341 | ||
| Guidelines on the investigation and management of antiphospholipid syndrome | Q37982121 | ||
| Interpretation and recommended testing for antiphospholipid antibodies | Q37991552 | ||
| Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome | Q38015047 | ||
| Catastrophic antiphospholipid syndrome (CAPS). | Q38049765 | ||
| Correct laboratory approach to APS diagnosis and monitoring. | Q38065593 | ||
| 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends | Q38211487 | ||
| APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking | Q39612633 | ||
| Clinical course of high-risk patients diagnosed with antiphospholipid syndrome | Q39934417 | ||
| Two antiprothrombin antibodies against prothrombin and prothrombin-phosphatidyl serine show partial but not total identity | Q40620711 | ||
| Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome | Q41619784 | ||
| Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with 'seronegative' antiphospholipid syndrome | Q43090289 | ||
| Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype | Q43850415 | ||
| GAPSS: the Global Anti-Phospholipid Syndrome Score | Q44993606 | ||
| IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis | Q45126748 | ||
| The global anti-phospholipid syndrome score in primary APS. | Q45130401 | ||
| Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. | Q50619255 | ||
| IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. | Q50933721 | ||
| Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. | Q51158264 | ||
| Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. | Q53159273 | ||
| Antiphospholipid syndrome | Q55891386 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 1255-1263 | |
| P577 | publication date | 2015-08-21 | |
| P1433 | published in | Expert Review of Clinical Immunology | Q15733763 |
| P1476 | title | The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome | |
| P478 | volume | 11 |
| Q50765317 | Cessation of oral anticoagulants in antiphospholipid syndrome. |
| Q37011051 | Detection of multiple annexin autoantibodies in a patient with recurrent miscarriages, fulminant stroke and seronegative antiphospholipid syndrome |
| Q38848271 | Independent validation of the adjusted GAPSS. Role of thrombotic risk assessment in the real-life setting. |
| Q40341423 | Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile. |
Search more.